| Korea | Russia | Malaysia
Indonesia | All Others

eg.stem cell, stem cell treatment
Stem cell treatment | Parkinson's Disease | Multiple Sclerosis | ALS | Brain Injury | Spinal Cord Injury | Cerebaral Palsy | Batten Disease | Stroke
MSA | Muscular Dystrophy | Epilepsy | Optic neuritis | Encephalomyelitis | SMA | Huntingdon's disease | Friedrich ataxia | Diabetes
HOME > News > Article Content

High Prevalence of Depression After Traumatic Brain Injury


http://www.sciencedaily.com/releases/2010/05/100518101616.htm

ScienceDaily (May 19, 2010)

During the year following hospitalization for a traumatic brain injury, a majority of patients experienced major depression, according to a study in the May 19 issue of JAMA, a theme issue on mental health.


Charles H. Bombardier, Ph.D., of the University of Washington School of Medicine, Seattle, presented the findings of the study at a JAMA media briefing on mental health.


"Traumatic brain injury (TBI) is a major cause of disability in the United States and a signa¬ture injury among wounded soldiers. Assessment and treatment of TBI typically focus on physical and cog¬nitive impairments, yet psychological impairments represent significant causes of disability. Major depressive disorder (MDD) may be the most com¬mon and disabling psychiatric condi¬tion in individuals with TBI. Poorer cognitive functioning, aggression and anxiety, greater functional disabil¬ity, poorer recovery, higher rates of suicide attempts, and greater health care costs are thought to be associ¬ated with MDD after TBI," the authors write.Uncertainties exist about the rates, predictors, and outcomes of major de¬pressive disorder among individuals with TBI.

Dr. Bombardier and colleagues conducted a study to determine the rate of MDD during the first year after TBI and also examined predictors of MDD, MDD-related co-existing illnesses and the relationship of MDD to quality-of-life outcomes. The study included 559 hospitalized adults with compli¬cated mild to severe TBI, who were followed up by structured tele¬phone interviews at months 1 through 6, 8, 10, and 12. Depression and anxiety were gauged with Patient Health Questionnaire (PHQ) study measures, which were administered at each assessment, and the European Quality of Life measure was given at 12 months.

The researchers found that during the first year after TBI, 297 of 559 patients (53.1 percent) met criteria for MDD at least once (a rate of MDD that is about 8 times greater than would be expected in the general population). The authors add that because of incomplete data at each assessment time point, the rate and depression duration estimates are likely conservative.

Participants were mostly men injured in vehicular crashes who sus¬tained complicated mild injuries. Point prevalences of MDD ranged between 31 percent at 1 month and 21 percent at 6 months. Risk of MDD after TBI was associated with MDD at the time of injury, history of MDD prior to injury (but not at the time of injury), age (individuals older than 60 years had a lower risk of MDD than those 18-29 years of age), and life¬time alcohol dependence.

Those with MDD also were more likely to report any co-existing anxiety disorders after TBI than those without MDD (60 percent vs. 7 percent). Only 44 percent of those with MDD received antidepres¬sants or counseling. Also, MDD within the first year after TBI was associated with greater problems with mobility, usual activities, and pain/discomfort and greater difficulty with role function¬ing at 12 months after TBI. After adjusting for predictors of MDD, persons with MDD re¬ported lower quality of life at 1 year compared with the nondepressed group.

The researchers write that several features of MDD after TBI are pertinent to future detection and treatment efforts, including the fact that about half of the pa¬tients who became depressed were iden¬tified by 3 months, suggesting a window of opportunity for early identification and treatment or prevention efforts. They note that TBI survivors remained at risk of MDD throughout the first year re¬gardless of pre-injury depression his¬tory, and that risk of post-TBI MDD probably persists beyond 1 year.
"Systematic integration of mental health services into standard care of patients with TBI may be needed to improve long-term outcomes after TBI. Within inpa¬tient rehabilitation, integrated clinical pathways can be used to organize early identification, risk assessment, diagno¬sis, and guideline-driven treatment of MDD. Systematic depression screen¬ing and stepped-care treatment proto¬cols should be integrated into routine outpatient care. For those without or be¬yond routine follow-up, novel case-finding programs may be useful, possi¬bly via scheduled telephone contacts, Internet-based screening or other tech¬nology-assisted methods," the authors write.



Related Information:

  • The Washington Post report regarding our center and specialized stem cell treatment   
  • Stem cell therapy, a promising novel endeavor for neurological disorders   
  • Major ALS breakthrough-common cause of all forms of ALS discovered   
  • Imaging Study Shows Slower Growth In Autistic Brains Extending Into Adolescence   
  • 'Pushing Limits' - New Drug Strategies For Alzheimer's, Multiple Sclerosis   
  • Study Suggests Varying Practice Sessions May Benefit People With Motor Disorders   
  • New Drug Strategies for Alzheimer's and Multiple Sclerosis   
  • Antiviral Drugs May Slow Alzheimer's Progression   
  • Precision With Stem Cells a Step Forward for Treating Multiple Sclerosis, Other Diseases   
  • Minority Children Less Likely to Receive CT Scans Following Head Trauma   
  • Reassurance for Dementia Sufferers On Impact of Common Drugs   
  • Understanding the Beginnings of Embryonic Stem Cells Helps Predict the Future   
  • By Reprogramming Skin Cells Into Brain Cells, Scientists Gain New Insights Into Mental Disorders   
  • Family History May Have More Important Role Than Previously Thought in Development of Alzheimer Disease   
  • Evidence Points to Potential Roles for Cognitive Rehabilitation Therapy in Treating Traumatic Brain Injury,   
  • New Drug Target for Alzheimer's, Stroke Discovered   
  • New Drug Target for Alzheimer's, Stroke Discovered   
  • A Safe Vaccination for Alzheimer's Disease?   
  • Think You're in Poor Health? It Could Increase Your Odds of Dementia   
  • Models of Autism Show That Gene Copy Number Controls Brain Structure and Behavior   
  • Patient-Specific Stem Cells: Major Step Toward Cell-Based Therapies for Life-Threatening Diseases   
  • One Quarter of Seniors Over 70 Have Had Silent Strokes   
  • Remitting Multiple Sclerosis: Natalizumab Reduces Relapses and Disability   
  • Seeds of Destruction in Parkinson's Disease: Spread of Diseased Proteins Kills Neurons   
  • Even High-But-Normal Blood Pressure Elevates Stroke Risk   
  • Commonly Used Supplement May Improve Recovery from Spinal Cord Injuries   
  • Key to Survival of Brain Cells Discovered   
  • Correcting Sickle Cell Disease With Stem Cells   
  • New Stem Cell Activity Identified in Human Brain   
  • New Stem Cell Activity Identified in Human Brain   
  • Treatment
    The Parkinson's Clinical Center
    Doctor Blogs
    Treatment Data
    Contact Us

  • What are stem cells and how do they work to treat various diseases?   
  • How do stem cells know where to go and what to do?   
  • What kinds of stem cells does your medical center use and are they safe?   
  • Where do the stem cells come from?   
  • Is stem cell treatment safe? Is it really effective?   
  • How do I know if I am a good candidate for stem cell therapy?   
  • How long should I expect to stay in Beijing for the treatment?   
  • Can you use adult stem cells from my own bone marrow?   
  • What methods do you use to transplant stem cells into the patient's body?   
  • What should I expect to experience during the stem cell treatment?   
  • Do the doctors use anesthesia during the operation?   
  • What other drugs does the doctor combine with the stem cells for therapy?   
  • How long after surgery will it be before I can bathe or shower?   
  • For Batten disease treatment, what type of stem cells are used?   
  • About the neural growth factors that your medical center use   
  • If your hospitals have an age restriction on patients?   
  • What medications do you use on Batten disease patients?   
  • Is it possible for you to manufacture the TPP1 enzyme and deliver it?   
  • When I send my records to your hospital, does a doctor read them?   
  • Is general anesthesia used?   
  • Is other therapy done in addition to stem cell infusion?   
  • What types of rehabilitation training is done?   
  • What will my treatment schedule be like?   
  • Does the doctor have to penetrate the spinal canal to infuse the stem cells   
  • If I have to have surgery, how long will it take for the wound to heal?   
  • Will I lose very much blood?   
  • If there is surgery, can I fly back home before the wound has healed?   
  • Does your medical center also offer conventional treatment?   
  • What is the most effective way to contact us?   
  • Are stem cells pre-tested for HIV and Hepatitis? What else do you test?   
  • Send Inquiry Contact Us Sitemap Help

    Link:Like Cell Research Center | stemcellshezhong.com
    Copyright © 2011 unistemcells.com All rights reserved.